rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2010-5-12
|
pubmed:abstractText |
Few data exist on the potential role of circulating tumor cells (CTCs) in patients with operable breast cancer. If the presence of CTCs in early breast cancer could predict an increased risk for relapse, it might be an early marker for treatment efficacy and could help in deciding treatment continuation.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1534-4681
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1539-45
|
pubmed:meshHeading |
pubmed-meshheading:20135356-Breast Neoplasms,
pubmed-meshheading:20135356-Female,
pubmed-meshheading:20135356-Humans,
pubmed-meshheading:20135356-Neoplasm Staging,
pubmed-meshheading:20135356-Neoplastic Cells, Circulating,
pubmed-meshheading:20135356-Postoperative Period,
pubmed-meshheading:20135356-Predictive Value of Tests,
pubmed-meshheading:20135356-Preoperative Period,
pubmed-meshheading:20135356-Treatment Outcome,
pubmed-meshheading:20135356-Tumor Markers, Biological
|
pubmed:year |
2010
|
pubmed:articleTitle |
Changes in circulating tumor cell detection in patients with localized breast cancer before and after surgery.
|
pubmed:affiliation |
Unit of Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, Milan, Italy. maria.sandri@ieo.it
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|